Clinical Trial Update: Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario

View source ↗

Summary

An ongoing real-world clinical study is examining outcomes in advanced ovarian cancer patients based on homologous recombination status and matched therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Consorzio Oncotech | Conditions: Ovarian Cancer | Status: RECRUITING